Related Experiment Video
Updated: Jun 26, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations.
R M Ruggeri1, L Santarpia, L Curtò
1Department of Medicine and Pharmacology, Section of Endocrinology, University of Messina, 98125 Messina, Italy. rmruggeri@unime.it
G-protein mutations are rare in non-functioning pituitary adenomas (NFPAs). Researchers found one GNAS1 mutation in 22 patients, suggesting these mutations are not key drivers of NFPA development.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Mutations in GNAS1 and GNAI2 genes, encoding G-proteins, are implicated in endocrine neoplasias, including pituitary tumors.
- Investigating these genetic alterations is crucial for understanding tumor pathogenesis.
Purpose of the Study:
- To investigate the presence of GNAS1 and GNAI2 mutations in a series of non-functioning pituitary adenomas (NFPAs).
- To assess the role of these G-protein mutations in the development of NFPAs.
Main Methods:
- PCR amplification and direct sequencing of hot spot exons (GNAS1 exons 8-9, GNAI2 exons 5-6) from 22 NFPA surgical samples.
- Investigation of the GNAI2 promoter region for single nucleotide polymorphisms (SNPs).
Main Results:
- A single GNAS1 mutation (CGT>TGT at codon 201) was identified in one NFPA case.
- No GNAI2 mutations were detected in the studied NFPA cohort.
- A silent SNP in the GNAI2 promoter was found in one patient.
Conclusions:
- G-protein mutations appear to be infrequent and not critically involved in the pathogenesis of NFPAs.
- The findings support the rarity of G-protein mutations as a significant factor in NFPA development.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Related Concept Videos
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Two...
GTPases and their Regulation
Large G-proteins, also known...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...